CBL and neoplasm: At the same time, c-Cbl inhibits tumor-induced angiogenesis by targeting the Wnt/β–catenin pathway, VEGFR-2 signaling, Angiopoietin(1/2)-Tie2 axis, and other tyrosine kinases [25].